发明名称 STABILIZED SOLID FORM CHOLINE SALICYLATE COMPOSITIONS
摘要 <p>Choline salicylate is stabilized in solid form by means of a metal salicylate having a valence of at least 2, preferably aluminum, bismuth, calcium or magnesium salicylate. The composition is stabilized to a still greater degree by the addition thereto of carboxy-methyl cellulose. A still greater degree of stabilization is achieved by forming a complex of the choline salicylate, metal salicylate and carboxy-methyl cellulose. The complex is formed by preparing a solution of the carboxy-methyl cellulose, choline salicylate and metal salicylate, permitting complexing reaction to take place and drying. All of these stabilized forms of choline salicylate are used in solid dosage forms such as granules, tablets, capsules and supporitories for administration to animals and humans, in the course of choline salicylate therapy, to elevate the blood levels of salicylate ion.</p>
申请公布号 CA1070299(A) 申请公布日期 1980.01.22
申请号 CA19760260766 申请日期 1976.09.08
申请人 PURDUE FREDERICK COMPANY (THE) 发明人 SASMOR, ERNEST J.
分类号 A61K31/60;A61K;A61K9/00;A61K9/14;A61K9/20;A61K31/015;A61K31/05;A61K31/08;A61K31/14;A61K31/19;A61K31/205;A61K31/235;A61K31/24;A61K31/28;A61K31/575;A61K31/715;A61K47/00;A61K47/12;A61K47/38;C07C;C07C51/00;C07C65/10;C07C67/00;C07C69/84;C07C69/86;C07C69/88;C07J9/00;C08B11/12;C08B11/20;C08B15/00;C08B15/05;C08B15/06;C08L1/26;(IPC1-7):07C91/26;08B11/12 主分类号 A61K31/60
代理机构 代理人
主权项
地址